Mather Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227K Buy
+907
New +$226K ﹤0.01% 700
2025
Q4
Sell
-686
Closed -$180K 1660
2025
Q3
$180K Buy
+686
New +$167K ﹤0.01% 652
2025
Q2
Sell
-884
Closed -$198K 1735
2025
Q1
$198K Sell
884
-225
-20% -$62K ﹤0.01% 591
2024
Q4
$363K Sell
1,109
-357
-24% -$112K ﹤0.01% 425
2024
Q3
$440K Buy
1,466
+143
+11% +$43.8K 0.01% 394
2024
Q2
$524K Buy
1,323
+142
+12% +$50.2K 0.01% 406
2024
Q1
$416K Hold
1,181
0.01% 377
2023
Q4
$416K Sell
1,181
-54
-4% -$19.1K 0.01% 388
2023
Q3
$463K Buy
1,235
+46
+4% +$17.8K 0.01% 339
2023
Q2
$455K Buy
1,189
+297
+33% +$106K 0.01% 366
2023
Q1
$309K Buy
+892
New +$261K 0.01% 389
2022
Q4
Sell
-1,011
Closed -$249K 513
2022
Q3
$249K Sell
1,011
-12
-1% -$3.66K 0.01% 410
2022
Q2
$309K Buy
+1,023
New +$333K 0.01% 303

Other funds holding WST